HomeALXO • NASDAQ
add
ALX Oncology Holdings Inc
Previous close
$0.44
Day range
$0.43 - $0.45
Year range
$0.41 - $15.35
Market cap
23.15M USD
Avg Volume
539.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 31.82M | -15.74% |
Net income | -30.75M | 13.57% |
Net profit margin | — | — |
Earnings per share | -0.48 | 32.64% |
EBITDA | -31.61M | 15.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 97.83M | -37.86% |
Total assets | 120.90M | -43.15% |
Total liabilities | 32.60M | -32.71% |
Total equity | 88.30M | — |
Shares outstanding | 53.44M | — |
Price to book | 0.26 | — |
Return on assets | -59.22% | — |
Return on capital | -67.57% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -30.75M | 13.57% |
Cash from operations | -24.66M | 34.97% |
Cash from investing | 27.64M | 4.43% |
Cash from financing | 65.00K | -97.89% |
Net change in cash | 3.05M | 136.43% |
Free cash flow | -13.92M | 47.99% |
About
Founded
2015
Headquarters
Website
Employees
65
